The top three molecular diagnostics companies in the US in 2026 are Cepheid, bioMérieux and Roche Diagnostics. That ranking is based on iData Research market share data for the U.S. molecular diagnos...Read More
Point of care testing is one of the fastest-growing segments within the U.S. in vitro diagnostics industry. Rather than sending a patient sample to a central laboratory and waiting hours for results, ...Read More
The leading in vitro diagnostics market companies are competing in a U.S. market valued at $23.9 billion in 2025, and projected to reach $31.8 billion at a 4.2% CAGR through the forecast period. This ...Read More
Top 5 Market Trends in In vitro Diagnostics The U.S. in vitro diagnostics (IVD) market continues to play a central role in modern healthcare. These tests, performed on blood, urine, and other samples,...Read More